Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)
CAPS Rating:
A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.
RSS Headlines
Fool UK
Recs
Onyx will get bought out within two years.